MORE stock is coming. Subway is pumping GTEC and getting paid shares for it:
"The SUBWAY to CRGP, CRG was compensated five million four hundred thousand restricted shares of Genesis Technology Group Inc. (GTEC). CRG also received six hundred thousand common shares of GTEC, and additional compensation of ten thousand dollars. CRG also purchased three hundred ten thousand GTEC shares in the open market. CRG has sold GTEC shares, and intends to continue to sell its shares and to purchase and sell additional shares of GTEC. An officer of CRG is the sole owner of a limited liability company (the LLC) that is a member of and owns 25 percent of Genesis Equity Partners (GEP) a limited liability company of which GTEC is a member and owns a fifty one percent interest. GEP is a general partner in a partnership agreement with Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) hereafter Lotus, a publicly traded company, whereby GEP for a period of 18 months is a non exclusive external consultant in connection with financial and related matters. Under that partnership agreement the members of GEP received Lotus stock; the LLC owned by an officer of CRG received 3,302,400 shares of Lotus stock. The LLC intends to sell its shares of Lotus. GEP also receives a fee of $10,000 per month from Lotus. CRGP intends to sell its shares. CRGP has sold approximately zero LTUS or GTEC shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site operates under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's Licensors, affiliates, officers, directors and employees own shares and intend to buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market."
